Hypertension Trial, Recruiting NCT04753840 Sponsor: Henan Institute of Cardiovascular Epidemiology Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT04753840
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with mild high blood pressure, meaning their top blood pressure number is between 140 and 159, and their bottom number is between 90 and 99

Who may not be able to join:

  • People who are unable to tolerate the arm compression procedure used in this trial (called RIPC) (confirm with trial site)
  • People whose high blood pressure is caused by an underlying medical condition, rather than being a primary diagnosis on its own
  • People who have uncontrolled serious heart rhythm problems, diabetes, or an imbalance of minerals in their blood
  • People who have serious organ-related conditions such as a recent heart attack, heart failure, or abnormal kidney function

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Muwei Li, MD, Chinese Academy of Medical Sciences, Fuwai Hospital

Phone: 13525070525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Henan Institute of Cardiovascular Epidemiology
Registry
ClinicalTrials.gov
Start date
3 July 2021
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Mean systolic blood pressure; Mean diastolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov